TransAct Technologies Reports Preliminary Third Quarter 2025 Financial Results
Sold 1,591 Terminals in the Third Quarter 2025, Bringing Nine Month Number to 5,883, Representing a
Total Quarterly FST Net Sales Up
Quarterly Casino and Gaming Net Sales Up
“We’re pleased with the progress we’ve made in FST, delivering
"Additionally, we strengthened our balance sheet during the quarter, which will support our growing focus on FST software. Combined with improving FST sales results, we believe our enhanced cash balance will allow us to tackle new market opportunities, increase flexibility in our offerings, and deliver greater value to both customers and shareholders over time.”
Third Quarter 2025 Financial Highlights
-
Net Sales: Net sales for the third quarter of 2025 were
, up$13.2 million 21% compared to for the third quarter of 2024 largely as a result of stronger sales in both our casino and gaming and FST markets.$10.9 million -
FST Recurring Revenue: FST recurring revenue for the third quarter of 2025 was
, which represents an increase of$3.3 million 13% compared to for the third quarter of 2024.$2.9 million -
Gross Profit: Gross profit for the third quarter of 2025 was
, resulting in gross margin of$6.6 million 49.8% , compared to gross profit of for the third quarter of 2024, resulting in a$5.2 million 48.1% gross margin. -
Operating income (loss): Operating income for the third quarter of 2025 was
, compared to an operating loss of$14 thousand for the second quarter of 2025 and$(258) thousand for the third quarter of 2024.$(837) thousand -
Net income (loss): Net income for the third quarter of 2025 was
, or$15 thousand per diluted share, based on 10.2 million weighted average common shares outstanding. This compares to a net loss for the third quarter of 2024 of$0.00 , or$(551) thousand per diluted share, based on 10.0 million weighted average common shares outstanding.$(0.06) -
EBITDA: EBITDA was
for the third quarter of 2025, compared to$142 thousand for the second quarter of 2025 and$28 thousand for the third quarter of 2024.$(533) thousand -
Adjusted EBITDA: Adjusted EBITDA was
for the third quarter of 2025, compared to$669 thousand in the second quarter of 2025 and$478 thousand for the third quarter of 2024.$(204) thousand
2025 Financial Outlook
-
Net Sales: The Company expects full year 2025 net sales of between
and$50 million , an increase from the previously forecasted low end of$53 million .$49 million -
Adjusted EBITDA: The Company continues to expect full year 2025 adjusted EBITDA to be between
(breakeven) and$0 .$1.5 million
Our outlook for non-GAAP adjusted EBITDA is presented only on a non-GAAP basis because not all of the information necessary for a quantitative reconciliation of this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure is available without unreasonable effort, primarily due to uncertainties relating to the occurrence or amount of these adjustments that may arise in the future. If one or more of the currently unavailable items is applicable, some items could be material, individually or in the aggregate, to GAAP reported results.
2025 Third Quarter Conference Call and Webcast
TransAct is hosting a conference call and webcast today, November 10, 2025, beginning at 4:30 p.m. ET to discuss the Company’s preliminary third quarter 2025 results and other matters. Both the call and the webcast are open to the general public. The conference call number is 877-704-4453 and the conference ID is 13756829. Please call ten minutes prior to the presentation to ensure that you are connected.
Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “About Us” followed by “Investor Relations,” then select “News & Events” followed by “Events & Presentations”), or directly at https://transacttech.gcs-web.com/events/event-details/transact-technologies-third-quarter-2025-earnings-call. Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.
Non-GAAP Financial Measures
TransAct is providing certain non-GAAP financial measures because the Company believes that these measures are helpful to investors and others in assessing the ongoing nature of what the Company’s management views as TransAct’s core operations. EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and financing charges and income taxes. The Company believes that these non-GAAP financial measures provide relevant and useful information to an investor evaluating the Company’s operating performance because these measures are: (i) widely used by investors to measure a company’s operating performance without regard to items that do not reflect the Company’s ongoing operations and are excluded from the calculation of such measures; (ii) used as financial measurements by lenders and other parties to evaluate creditworthiness; and (iii) used by the Company’s management for various purposes including strategic planning and forecasting and assessing financial performance. The presentation of this non-GAAP information is not considered superior to or a substitute for, and should be read in conjunction with, the financial information prepared in accordance with GAAP.
EBITDA is defined as net income (loss) before net interest income, income taxes, depreciation, and amortization. A reconciliation of EBITDA to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.
Adjusted EBITDA is defined as net income (loss) before net interest income, income taxes, depreciation and amortization and is adjusted for (1) share-based compensation expense and (2) any other items, when they occur, that we believe do not reflect the ordinary earnings of the Company’s ongoing business. The Company adjusts EBITDA for share-based compensation because the Company considers share-based compensation expense to be a non-cash expense similar to depreciation and amortization. A reconciliation of adjusted EBITDA to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.
About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a global leader in developing and selling software-driven technology and integrated printing solutions for large and emerging markets including food service, casino and gaming, and POS automation. The Company’s solutions are designed from the ground up based on customer requirements and are sold under the BOHA!®, AccuDate®, EPICENTRAL®, Epic and Ithaca® brands. TransAct has sold over 4.0 million printers, terminals and other hardware devices around the world and is committed to providing world-class service, spare parts, and accessories to support its installed product base. Through the TransAct Services Group, the Company also provides customers with a complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct is headquartered in
©2025 TRANSACT Technologies Incorporated. All rights reserved. TransAct®, BOHA!®, AccuDate®, Epic Edge®, EPICENTRAL® and Ithaca® are registered trademarks of TransAct Technologies Incorporated.
Cautionary Statement Regarding Preliminary Financial Information
The Company has prepared the preliminary financial information set forth below on a materially consistent basis with its historical financial information and in good faith based upon its internal reporting as of and for the three and nine months ended September 30, 2025. This financial information is preliminary and is thus inherently uncertain and subject to change as the Company finalizes its financial results and related review for the three and nine months ended September 30, 2025. During the course of the preparation of the Company’s condensed consolidated financial statements and related notes as of and for the three and nine months ended September 30, 2025, the Company may identify items that could cause its final reported results to be materially different from the preliminary financial information set forth above. As a result, there can be no assurance that the Company’s final results for this period will not differ from the preliminary financial information.
This preliminary financial information should not be viewed as a substitute for full financial statements prepared in accordance with GAAP. In addition, this preliminary financial information is not necessarily indicative of the results to be achieved for any future period.
Forward-Looking Statements
Certain statements included in this press release are forward-looking statements within the meaning of the
- Financial tables follow-
TRANSACT TECHNOLOGIES INCORPORATED |
||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||
(Preliminary and Unaudited) |
||||||||
|
|
Three months ended |
|
Nine months ended |
||||
|
|
September 30, |
|
September 30, |
||||
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
(In thousands, except per share data) |
||||||
|
|
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
|
|
|
Cost of sales |
|
6,620 |
|
5,640 |
|
20,460 |
|
16,192 |
Gross profit |
|
6,556 |
|
5,227 |
|
19,567 |
|
16,961 |
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
Engineering, design and product development |
|
1,656 |
|
1,640 |
|
5,016 |
|
5,405 |
Selling and marketing |
|
2,091 |
|
1,880 |
|
6,279 |
|
6,160 |
General and administrative |
|
2,795 |
|
2,544 |
|
8,531 |
|
7,972 |
|
|
6,542 |
|
6,064 |
|
19,826 |
|
19,537 |
Operating income (loss) |
|
14 |
|
(837) |
|
(259) |
|
(2,576) |
|
|
|
|
|
|
|
|
|
Interest and other income (expense): |
|
|
|
|
|
|
|
|
Interest, net |
|
61 |
|
42 |
|
123 |
|
116 |
Other, net |
|
(35) |
|
96 |
|
143 |
|
43 |
|
|
26 |
|
138 |
|
266 |
|
159 |
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
40 |
|
(699) |
|
7 |
|
(2,417) |
Income tax (expense) benefit |
|
(25) |
|
148 |
|
(116) |
|
511 |
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common share: |
|
|
|
|
|
|
|
|
Basic |
|
|
|
|
|
|
|
|
Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used in per share calculation: |
|
|
|
|
|
|
|
|
Basic |
|
10,103 |
|
10,006 |
|
10,077 |
|
9,992 |
Diluted |
|
10,157 |
|
10,006 |
|
10,077 |
|
9,992 |
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL INFORMATION – SALES BY MARKET: |
|||||||
(Preliminary and Unaudited) |
|||||||
|
Three months ended |
Nine months ended |
|||||
|
September 30, |
|
September 30, |
||||
|
2025 |
2024 |
|
2025 |
2024 |
||
|
(In thousands) |
||||||
|
|
|
|
|
|
||
Food service technology |
|
|
|
|
|
||
POS automation |
399 |
1,148 |
|
1,607 |
2,950 |
||
Casino and gaming |
7,144 |
4,534 |
|
21,492 |
15,589 |
||
TransAct Services Group |
792 |
864 |
|
2,418 |
2,815 |
||
Total net sales |
|
|
|
|
|
||
TRANSACT TECHNOLOGIES INCORPORATED |
||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||
(Preliminary and Unaudited) |
||||
|
|
September 30, |
|
December 31, |
|
|
2025 |
|
2024 |
|
|
(In thousands) |
||
Assets: |
|
|
|
|
Current assets: |
|
|
|
|
Cash and cash equivalents |
|
|
|
|
Accounts receivable, net |
|
5,839 |
|
6,507 |
Inventories |
|
11,735 |
|
16,161 |
Prepaid income taxes |
|
430 |
|
401 |
Other current assets |
|
1,111 |
|
899 |
Total current assets |
|
39,156 |
|
38,362 |
|
|
|
|
|
Fixed assets, net |
|
1,389 |
|
1,818 |
Right-of-use assets, net |
|
419 |
|
1,141 |
Goodwill |
|
2,621 |
|
2,621 |
Intangible assets, net |
|
1,352 |
|
- |
Other assets |
|
46 |
|
92 |
|
|
5,827 |
|
5,672 |
Total assets |
|
|
|
|
|
|
|
|
|
Liabilities and Shareholders’ Equity: |
|
|
|
|
Current liabilities: |
|
|
|
|
Revolving loan payable |
|
|
|
|
Accounts payable |
|
3,703 |
|
4,569 |
Accrued liabilities |
|
4,543 |
|
3,253 |
Lease liabilities |
|
437 |
|
955 |
Deferred revenue |
|
1,143 |
|
1,107 |
Total current liabilities |
|
12,826 |
|
12,884 |
|
|
|
|
|
Deferred revenue, net of current portion |
|
343 |
|
246 |
Lease liabilities, net of current portion |
|
- |
|
231 |
Other liabilities |
|
36 |
|
40 |
|
|
379 |
|
517 |
Total liabilities |
|
13,205 |
|
13,401 |
|
|
|
|
|
Shareholders’ equity: |
|
|
|
|
Common stock |
|
141 |
|
141 |
Additional paid-in capital |
|
59,357 |
|
58,141 |
Retained earnings |
|
4,406 |
|
4,515 |
Accumulated other comprehensive loss, net of tax |
|
(16) |
|
(54) |
Treasury stock, at cost |
|
(32,110) |
|
(32,110) |
Total shareholders’ equity |
|
31,778 |
|
30,633 |
Total liabilities and shareholders’ equity |
|
|
|
|
|
|
|
|
|
TRANSACT TECHNOLOGIES INCORPORATED |
||||||||
RECONCILIATION OF NET INCOME (LOSS) TO EBITDA AND ADJUSTED EBITDA |
||||||||
NON-GAAP FINANCIAL MEASURES |
||||||||
(Preliminary and Unaudited) |
||||||||
|
|
Three months ended |
|
Nine months ended |
||||
|
|
September 30, |
|
September 30, |
||||
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
(In thousands) |
||||||
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income, net |
|
(61) |
|
(42) |
|
(123) |
|
(116) |
Income tax expense (benefit) |
|
25 |
|
(148) |
|
116 |
|
(511) |
Depreciation and amortization |
|
163 |
|
208 |
|
507 |
|
844 |
|
|
|
|
|
|
|
|
|
EBITDA |
|
142 |
|
(533) |
|
391 |
|
(1,689) |
|
|
|
|
|
|
|
|
|
Share-based compensation expense |
|
527 |
|
329 |
|
1,300 |
|
873 |
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
|
|
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20251110071252/en/
Investor Contact:
Ryan Gardella
ICR, Inc.
Ryan.Gardella@icrinc.com
Source: TransAct Technologies Incorporated